Table 2 Summary of the economic evaluations in LMICs reported in the literature review

Hydrocele

Surgical interventions

Yellu (2010)

NA

NA

Yaws

Sequential testing: treponemal RDT before a trep/non-trep RDT

Fitzpatrick 2017

ICER is US$ 58 (42–103) per correct diagnosis gained

NA

Onchocerciasis

Ivermectin MDA (OCP, APOC, or Annual MDA)

Turner 2019 (plus 8 CBA and 7 CEAs included in this);

Kim 2015

(non-E.E.s reporting economic info on interventions:

Boussineq 2018; Turner 2013; Verver 2018 – see text below)

See Table 2 of Turner 2019

e.g.

$13.4 per healthy life-year added (Benton 1998, APOC, cost horizon 1996-2017),

$7 per DALY averted (Remme et al. 2006; APOC; cost horizon 25 years)

See Table 3 of Turner 2019

Lymphoedema

MDA (drug combinations unclear) (e.g. GPELF)

Gedge 2018 (and 12 E. Es included in this)

See Table 1 of Gedge 2018

e.g. $5.90 per DALY averted (Ottesen 2006, Annual MDA, 30 year time horizon).

See Table 2 of Gedge et al. 2018